GAMMA Investing’s Minerva Neurosciences NERV Stock Holding History

GAMMA Investing’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$972	Buy	+290	New	+$1.24K	﹤0.01%	4106

Other funds holding NERV

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's NERV Position: Q3 2026 in Review

GAMMA Investing opened a new position in Minerva Neurosciences (NERV) in Q3 2026: 290 shares worth $972. The stake represents ﹤0.01% of the portfolio and ranks #4106 among its holdings.

5 funds tracked by Wall St. Rank hold NERV as of Q3 2026.

GAMMA Investing held 290 shares of Minerva Neurosciences worth $972 as of Q3 2026.
Minerva Neurosciences was a new GAMMA Investing position in Q3 2026.
Minerva Neurosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4106 holding.
5 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.